We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.83%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$851B
AUM Growth
+$80.9B
Cap. Flow
+$19.9B
Cap. Flow %
2.34%
Top 10 Hldgs %
25.93%
Holding
4,889
New
83
Increased
3,362
Reduced
611
Closed
132

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.18B
2
AAPL icon
Apple
AAPL
+$1.11B
3
AVGO icon
Broadcom
AVGO
+$562M
4
AMZN icon
Amazon
AMZN
+$553M
5
PANW icon
Palo Alto Networks
PANW
+$485M

Sector Composition

Rank Sector Weight
1 Technology 28.24%
2 Healthcare 13.33%
3 Financials 12.09%
4 Consumer Discretionary 10.85%
5 Industrials 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRML
3551
DELISTED
Tourmaline Bio
TRML
$633K ﹤0.01%
20,810
-20,001
-49% -$511K
GAN
3552
DELISTED
GAN Ltd
GAN
$632K ﹤0.01%
385,450
-22,150
-5% -$31.5K
PEPL
3553
DELISTED
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
$630K ﹤0.01%
60,360
+532
+0.9% +$5.5K
TESS
3554
DELISTED
Tessco Technologies Inc
TESS
$628K ﹤0.01%
70,179
+8,095
+13% +$68.2K
CHCI icon
3555
Comstock Holding Companies
CHCI
$145M
$628K ﹤0.01%
149,823
+1,330
+0.9% +$5.62K
MDWT
3556
DELISTED
Midwest Holding Inc. Common Stock
MDWT
$627K ﹤0.01%
23,406
+7,594
+48% +$170K
PMCB icon
3557
PharmaCyte Biotech
PMCB
$6.18M
$627K ﹤0.01%
219,074
+43,810
+25% +$131K
INVZ icon
3558
Innoviz Technologies
INVZ
$95M
$623K ﹤0.01%
219,293
+665
+0.3% +$1.83K
PYXS icon
3559
Pyxis Oncology
PYXS
$168M
$622K ﹤0.01%
242,787
+3,436
+1% +$10.9K
GANX icon
3560
Gain Therapeutics
GANX
$71.7M
$621K ﹤0.01%
138,721
+44,514
+47% +$217K
ENZ
3561
DELISTED
Enzo Biochem, Inc.
ENZ
$621K ﹤0.01%
337,575
-17,467
-5% -$40.4K
VCSA
3562
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$621K ﹤0.01%
45,764
-54,945
-55% -$825K
STRT icon
3563
STRATTEC Security
STRT
$367M
$618K ﹤0.01%
33,941
LNKB
3564
DELISTED
LINKBANCORP
LNKB
$614K ﹤0.01%
102,351
+22,989
+29% +$134K
SCX
3565
DELISTED
The L.S. Starrett Company
SCX
$612K ﹤0.01%
58,545
LYRA
3566
DELISTED
LYRA THERAPEUTICS INC
LYRA
$612K ﹤0.01%
2,977
CLS icon
3567
Celestica
CLS
$38.1B
$611K ﹤0.01%
41,263
+128
+0.3% +$1.58K
INTR icon
3568
Inter&Co
INTR
$2.47B
$607K ﹤0.01%
193,963
+48,969
+34% +$117K
UBCP icon
3569
United Bancorp
UBCP
$90.7M
$603K ﹤0.01%
50,466
ITRN icon
3570
Ituran Location and Control
ITRN
$1.09B
$600K ﹤0.01%
25,723
+801
+3% +$18K
CURV icon
3571
Torrid Holdings
CURV
$254M
$600K ﹤0.01%
213,410
-13,879
-6% -$44.3K
BBAI icon
3572
BigBear.ai
BBAI
$1.34B
$600K ﹤0.01%
+255,145
New +$647K
COOL
3573
DELISTED
Corner Growth Acquisition Corp. Class A Ordinary Shares
COOL
$599K ﹤0.01%
56,198
WKME
3574
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
$594K ﹤0.01%
61,924
+12,066
+24% +$117K
GHRS icon
3575
GH Research
GHRS
$1.93B
$594K ﹤0.01%
50,029
+209
+0.4% +$2.14K

Similar funds

Geode Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Geode Capital Management held 4,889 positions worth $851B, up 11% from $770B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4.4%. Geode Capital Management opened 83 new positions and exited 132, leaving the 4,889-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q2 2023 buy was Coupang: 4,567,454 shares worth $79.5M.
  • Geode Capital Management added most to Microsoft in Q2 2023, an estimated $1.18B increase.
  • Geode Capital Management's biggest Q2 2023 reduction was Procter & Gamble, cutting an estimated $246M.
  • Geode Capital Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $111M.
  • Geode Capital Management's ten largest holdings make up 26% of its $851B portfolio in Q2 2023.
  • Geode Capital Management opened 83 new positions and closed 132 in Q2 2023.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $851B.

Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.